Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: Structure based design, synthesis, SAR and antimicrobial activity

被引:48
作者
Yule, Ian A. [1 ]
Czaplewski, Lloyd G. [2 ]
Pommier, Stephanie [2 ]
Davies, David T. [2 ]
Narramore, Sarah K. [1 ]
Fishwick, Colin W. G. [1 ]
机构
[1] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England
[2] Biota Europe Ltd, Begbroke OX5 1PF, Oxon, England
基金
英国工程与自然科学研究理事会;
关键词
Bacterial resistance; DNA gyrase; Pyridine-3-carboxamide; Molecular modelling; TOPOISOMERASE-IV; ANTIBACTERIAL AGENTS; UREA INHIBITORS; NO ESKAPE; RESISTANCE; DISCOVERY; DRUGS; PARE;
D O I
10.1016/j.ejmech.2014.08.025
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The development of antibacterial drugs based on novel chemotypes is essential to the future management of serious drug resistant infections. We herein report the design, synthesis and SAR of a novel series of N-ethylurea inhibitors based on a pyridine-3-carboxamide scaffold targeting the ATPase sub-unit of DNA gyrase. Consideration of structural aspects of the GyrB ATPase site has aided the development of this series resulting in derivatives that demonstrate excellent enzyme inhibitory activity coupled to potent Gram positive antibacterial efficacy. (c) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 20 条
  • [1] Regioselective preparation of pyridin-2-yl ureas from 2-chloropyridines catalyzed by Pd(0)
    Abad, A
    Agulló, C
    Cuñat, AC
    Vilanova, C
    [J]. SYNTHESIS-STUTTGART, 2005, (06): : 915 - 924
  • [2] Resistance to antibiotics: Are we in the post-antibiotic era?
    Alanis, AJ
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (06) : 697 - 705
  • [3] Fragment-to-Hit-to-Lead Discovery of a Novel Pyridylurea Scaffold of ATP Competitive Dual Targeting Type II Topoisomerase Inhibiting Antibacterial Agents
    Basarab, Gregory S.
    Manchester, John I.
    Bist, Shanta
    Boriack-Sjodin, P. Ann
    Dangel, Brian
    Illingworth, Ruth
    Sherer, Brian A.
    Sriram, Shubha
    Uria-Nickelsen, Maria
    Eakin, Ann E.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (21) : 8712 - 8735
  • [4] Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
    Boucher, Helen W.
    Talbot, George H.
    Bradley, John S.
    Edwards, John E., Jr.
    Gilbert, David
    Rice, Louis B.
    Scheld, Michael
    Spellberg, Brad
    Bartlett, John
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) : 1 - 12
  • [5] Bur D., 2011, ANTIBACTERIAL ISOQUI
  • [6] Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: Intelligent design and evolution through the judicious use of structure-guided design and stucture-activity relationships
    Charifson, Paul S.
    Grillot, Anne-Laure
    Grossman, Trudy H.
    Parsons, Jonathan D.
    Badia, Michael
    Bellon, Steve
    Deininger, David D.
    Drumm, Joseph E.
    Gross, Christian H.
    LeTiran, Arnaud
    Liao, Yusheng
    Mani, Nagraj
    Nicolau, David P.
    Perola, Emanuele
    Ronkin, Steven
    Shannon, Dean
    Swenson, Lora L.
    Tang, Qina
    Tessier, Pamela R.
    Tian, Ski-Kai
    Trudeau, Martin
    Wang, Tiansheng
    Wei, Yunyi
    Zhang, Hong
    Stamos, Dean
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (17) : 5243 - 5263
  • [7] Czaplewski L. G., 2013, [No title captured], Patent No. [WO 2013/091011 A1, 2013091011]
  • [8] East SP, 2012, RSC DRUG DISCOV, V21, P335, DOI 10.1039/9781849734912-00335
  • [9] DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: Synthesis and antibacterial activity
    East, Stephen P.
    White, Clara Bantry
    Barker, Oliver
    Barker, Stephanie
    Bennett, James
    Brown, David
    Boyd, E. Andrew
    Brennan, Christopher
    Chowdhury, Chandana
    Collins, Ian
    Convers-Reignier, Emmanuelle
    Dymock, Brian W.
    Fletcher, Rowena
    Haydon, David J.
    Gardiner, Mihaly
    Hatcher, Stuart
    Ingram, Peter
    Lancett, Paul
    Mortenson, Paul
    Papadopoulos, Konstantinos
    Smee, Carol
    Thomaides-Brears, Helena B.
    Tye, Heather
    Workman, James
    Czaplewski, Lloyd G.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 894 - 899
  • [10] The 10 x '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
    Gilbert, David N.
    Guidos, Robert J.
    Boucher, Helen W.
    Talbot, George H.
    Spellberg, Brad
    Edwards, John E., Jr.
    Scheld, W. Michael
    Bradley, John S.
    Bartlett, John G.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (08) : 1081 - 1083